Lyell Immunopharma Inc.

NASDAQ: LYEL · Real-Time Price · USD
10.93
0.17 (1.58%)
At close: Aug 15, 2025, 11:16 AM

Lyell Immunopharma Revenue

Lyell Immunopharma reported an annual revenue of $61K, reflecting a -53.08% growth. For the quarter ending June 30, 2025, Lyell Immunopharma generated $8K in revenue.
Revenue (ttm)
61K
Revenue Growth
-53.08%
Price / Sales Ratio
54867.93
Revenue / Employee
203.33
Employees
300
Market Cap
209.98M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.